Recent Updates
Recently added Catalysts
GRFS Negative Sentiment Score: 30/100

Grifols deaths and harm: Patient safety & options for accountability

Key Takeaway: A press conference will address patient safety concerns regarding Grifols, a major plasma product manufacturer. The event will highlight reported adverse events, legal rights of patients, and the need for regulatory accountability. Despite serious compliance issues, Grifols continues to operate in Canada under a monopoly contract. The discussion aims to enhance public confidence in blood and plasma systems.
Price reaction · baseline $7.29 (2026-07-09 close) · hit pre-market · clean, no other GRFS news in the window
day 0 close
-0.3%

Market Sentiment Analysis

CONCERNS & RISKS

  • Two deaths reported after plasma harvesting at Grifols centers.
  • Patients have experienced hospitalizations linked to Grifols' practices.
  • Grifols has faced numerous compliance issues during inspections.
  • Controversial practices include financial incentives for donors.

Full Press Release Details

TORONTO, July 10, 2026 (GLOBE NEWSWIRE) -- Will Trial Lawyers and the Ontario Health Coalition invite members of the media to attend a press conference regarding patient safety issues related to Grifols, one of the world's largest manufacturers of plasma-derived medical products. The media conference will examine issues surrounding public safety and reported adverse events; patients’ legal rights and available supports; regulatory oversight, transparency, and accountability. Speakers will discuss patients' legal rights, the importance of reporting adverse events, and measures that can strengthen public confidence in Canada's blood and plasma systems.
Date:July 13, 2026Time:10:30 AMBy Zoom:Media are invited to register here:https://us06web.zoom.us/meeting/register/mgc6yMZaSPeTNcSknWZjrgand Zoom will email the link.Speakers:Representatives from Will Trial Lawyers, Representatives from the Ontario Health Coalition
Background:Canadian Blood Services has given a 15-year monopoly contract to Grifols to extract plasma and manufacture plasma-derived products from Canadians. Health Canada has approved Grifols to operate in Canada and take plasma at double the rate that Canadian Blood Services does. The contract is controversial due to Grifols’ practices, including offering financial incentives to donors to donate frequently and the selling products derived from Canadians’ plasma internationally. Two people died after having their plasma harvested at Grifols’ centres and others have reported hospitalizations.
Canadian Blood Services and Health Canada have continued to allow Grifols to operate despite numerous serious issues of non-compliance in inspections. Currently British Columbia and Quebec ban paid plasma by provincial law and Newfoundland and PEI have no paid plasma centres. Ontario has a Voluntary Blood Donations Act (2014) that bans paid plasma by private entities but Grifols has been allowed to operate in this province by the Ford government regardless. The Health Coalition notes that the Ontario Act does not contain any agency clause “loophole” allowing Canadian Blood Services to contract Grifols to buy and sell plasma in this province legally.
Will Trial Lawyersis a Canadian law firm representing individuals and families in complex medical negligence, class actions, product liability, and personal injury litigation. The firm advocates for accountability and access to justice for those harmed by negligent conduct or unsafe products.Contact:Michael Reid, 905-337-9748,mreid@willtriallawyers.ca
The Ontario Health Coalitionis a non-partisan public interest organization dedicated to protecting and improving Ontario's public health care system through advocacy, research and public education. The OHC represents more than 750,000 Ontarians in its network of more than 500 member organizations, 50 local chapters and individuals.Contact:Natalie Mehra, executive director 416-230-6402,info@ontariohc.ca.

Frequently Asked Questions

What is the purpose of the press conference?

The press conference aims to address patient safety issues related to Grifols and discuss legal rights and regulatory oversight.

What issues have been reported with Grifols?

Reported issues include two deaths and hospitalizations linked to plasma harvesting at Grifols centers.

Who is organizing the press conference?

The press conference is organized by Will Trial Lawyers and the Ontario Health Coalition.

What practices of Grifols are controversial?

Controversial practices include offering financial incentives to donors and selling plasma-derived products internationally.

What is the current status of paid plasma in Canada?

British Columbia and Quebec ban paid plasma, while Ontario allows Grifols to operate despite existing laws.

Last updated: Jul 10, 2026